Divi's Laboratories
Divi's Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana, India. It is one of the leading manufacturers of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical industry. The company is known for its focus on research and development and its commitment to quality and sustainability.
History[edit]
Divi's Laboratories was founded in 1990 by Dr. Murali K. Divi. Initially, the company focused on developing commercial processes for the manufacturing of APIs and intermediates. Over the years, Divi's has expanded its operations and established itself as a key player in the pharmaceutical industry.
Operations[edit]
Divi's Laboratories operates through two main divisions: the Generic API division and the Custom Synthesis division. The Generic API division focuses on the development and production of generic APIs, while the Custom Synthesis division provides contract manufacturing services to pharmaceutical companies worldwide.
Manufacturing Facilities[edit]
The company has several manufacturing facilities located in India, including:
- Unit I in Hyderabad, Telangana
- Unit II in Visakhapatnam, Andhra Pradesh
These facilities are equipped with state-of-the-art technology and adhere to stringent quality standards to ensure the production of high-quality pharmaceutical products.
Research and Development[edit]
Divi's Laboratories places a strong emphasis on research and development. The company invests significantly in R&D to develop innovative processes and improve existing ones. This focus on R&D enables Divi's to maintain a competitive edge in the pharmaceutical industry.
Sustainability and Corporate Social Responsibility[edit]
Divi's Laboratories is committed to sustainable practices and corporate social responsibility. The company implements environmentally friendly processes and actively engages in community development initiatives. These efforts reflect Divi's dedication to contributing positively to society and the environment.
Related Pages[edit]
- Pharmaceutical industry in India
- Active pharmaceutical ingredient
- Contract manufacturing organization
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian